CN Stock MarketDetailed Quotes

002873 Guiyang Xintian Pharmaceutical

Watchlist
  • 11.05
  • +0.19+1.75%
Market Closed Dec 13 15:00 CST
2.49BMarket Cap46.04P/E (TTM)

Guiyang Xintian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-14.80%660.85M
-16.01%441.7M
-15.06%177.32M
-12.29%953.98M
-10.76%775.67M
0.26%525.91M
-16.24%208.76M
12.15%1.09B
16.63%869.23M
15.53%524.54M
Operating revenue
-14.80%660.85M
-16.01%441.7M
-15.06%177.32M
-12.29%953.98M
-10.76%775.67M
0.26%525.91M
-16.24%208.76M
12.15%1.09B
16.63%869.23M
15.53%524.54M
Other operating revenue
----
-11.64%302.94K
----
-17.94%726.17K
----
-21.27%342.83K
----
--884.89K
----
-3.67%435.46K
Total operating cost
-9.51%609.5M
-14.47%403.64M
-13.40%158.94M
-9.95%870.96M
-10.17%673.53M
3.63%471.9M
-14.64%183.52M
12.64%967.23M
16.29%749.81M
14.63%455.36M
Operating cost
-2.76%172.47M
-7.10%111.79M
-14.15%39.31M
-11.54%218.76M
-8.39%177.36M
6.46%120.33M
-10.96%45.79M
22.93%247.29M
25.99%193.6M
21.01%113.03M
Operating tax surcharges
10.36%12.62M
11.44%7.65M
-0.46%3.44M
-1.20%13.04M
-2.07%11.44M
10.11%6.86M
-20.47%3.46M
-4.87%13.2M
2.87%11.68M
-2.77%6.23M
Operating expense
-19.93%271.3M
-28.62%180.03M
-22.78%77.38M
-17.79%437.54M
-20.87%338.81M
-3.36%252.22M
-17.81%100.21M
12.74%532.2M
16.67%428.14M
17.63%260.98M
Administration expense
-7.18%103.9M
-3.22%70.36M
12.69%29.9M
6.83%151.48M
12.98%111.94M
11.23%72.7M
-13.65%26.54M
5.53%141.79M
10.71%99.08M
10.34%65.36M
Financial expense
74.40%19.3M
78.32%12.41M
3.67%3.67M
7.50%12.01M
133.64%11.07M
296.71%6.96M
18.76%3.54M
-33.90%11.17M
-59.10%4.74M
-78.63%1.75M
-Interest expense (Financial expense)
69.78%19.61M
77.37%12.77M
3.66%3.85M
10.58%11.8M
121.37%11.55M
258.28%7.2M
18.49%3.71M
-35.71%10.67M
-58.65%5.22M
-77.79%2.01M
-Interest Income (Financial expense)
-51.64%-532.66K
-24.99%-405.93K
0.42%-199.21K
-26.54%-924.33K
34.88%-351.27K
0.79%-324.78K
-31.95%-200.05K
46.79%-730.48K
53.69%-539.45K
66.50%-327.35K
Research and development
30.54%29.91M
66.84%21.4M
31.17%5.23M
76.67%38.13M
82.29%22.92M
60.22%12.83M
11.16%3.99M
5.93%21.58M
7.31%12.57M
-1.34%8.01M
Credit Impairment Loss
-34.76%-4.07M
-1.95%-2.73M
-1,536.08%-1.09M
170.30%3.31M
53.02%-3.02M
30.47%-2.68M
91.35%-66.53K
-61.45%-4.71M
-76.66%-6.42M
-84.31%-3.85M
Asset Impairment Loss
97.78%-10.03K
103.49%14.8K
----
-71.22%-630.02K
-27.87%-451.3K
-83.03%-423.96K
-116.47%-383.35K
-340.75%-367.97K
-412.13%-352.93K
-142.28%-231.63K
Other net revenue
898.95%18.67M
-126.84%-382.81K
-75.81%159.86K
625.12%10.72M
170.62%1.87M
183.44%1.43M
57.76%660.86K
-74.17%1.48M
-372.14%-2.65M
-209.92%-1.71M
Fair value change income
158.82%10.14K
138.10%4.06K
358.33%15.72K
-3,500.00%-17.24K
---17.24K
---10.65K
---6.09K
--507.18
----
----
Invest income
----
----
----
-78.54%-707.21K
--0.16
----
----
---396.11K
----
----
Asset deal income
--18.9M
--32.47K
--32.47K
--0
----
----
----
82.02%-17.1K
82.02%-17.1K
82.02%-17.1K
Other revenue
-28.42%3.83M
-49.43%2.3M
7.46%1.2M
25.77%8.76M
29.15%5.35M
89.91%4.54M
-18.17%1.12M
-20.99%6.97M
-13.11%4.15M
38.27%2.39M
Operating profit
-32.68%70.01M
-32.03%37.68M
-28.39%18.55M
-23.11%93.74M
-10.94%104.01M
-17.84%55.43M
-25.24%25.9M
4.34%121.92M
15.10%116.78M
19.96%67.47M
Add:Non operating Income
-60.93%108.55K
-51.92%103.56K
-70.75%84.04K
45.89%371.33K
154.82%277.86K
168.89%215.39K
355.55%287.28K
-32.08%254.53K
-39.38%109.04K
-7.79%80.1K
Less:Non operating expense
39.66%1.86M
2,152.41%1.71M
777.16%312.93K
105.25%1.7M
316.97%1.33M
-31.79%76.11K
-48.51%35.68K
-1.57%826.93K
-78.89%318.57K
-90.97%111.58K
Total profit
-33.69%68.27M
-35.10%36.07M
-29.95%18.32M
-23.84%92.42M
-11.68%102.96M
-17.60%55.57M
-24.50%26.15M
4.27%121.34M
16.41%116.57M
22.41%67.44M
Less:Income tax cost
-52.33%7.27M
-38.04%5.73M
159.79%2.74M
17.50%11.55M
30.48%15.24M
-7.49%9.24M
-71.86%1.06M
-41.86%9.83M
4.31%11.68M
21.01%9.99M
Net profit
-30.45%61M
-34.51%30.34M
-37.94%15.57M
-27.48%80.87M
-16.38%87.71M
-19.36%46.33M
-18.74%25.09M
12.11%111.52M
17.94%104.89M
22.65%57.45M
Net profit from continuing operation
-30.45%61M
-34.51%30.34M
-37.94%15.57M
-27.48%80.87M
-16.38%87.71M
-19.36%46.33M
-18.74%25.09M
12.64%111.52M
17.94%104.89M
22.65%57.45M
Net profit of parent company owners
-30.45%61M
-34.51%30.34M
-37.94%15.57M
-27.48%80.87M
-16.38%87.71M
-19.36%46.33M
-18.74%25.09M
12.11%111.52M
17.94%104.89M
22.65%57.45M
Earning per share
Basic earning per share
-30.06%0.2645
-34.30%0.1312
-37.80%0.0673
-27.45%0.3489
-16.38%0.3782
-19.41%0.1997
-18.89%0.1082
9.87%0.4809
-18.05%0.4523
-15.37%0.2478
Diluted earning per share
-25.68%0.2645
-30.47%0.1312
-39.08%0.0622
-27.78%0.3307
-15.94%0.3559
-18.91%0.1887
-18.45%0.1021
12.56%0.4579
-19.23%0.4234
-15.90%0.2327
Other composite income
-165.77%-66.55M
663.07%101.19M
Other composite income of parent company owners
----
----
----
-165.77%-66.55M
----
----
----
663.07%101.19M
----
----
Total composite income
-30.45%61M
-34.51%30.34M
-37.94%15.57M
-93.27%14.32M
-16.38%87.71M
-19.36%46.33M
-18.74%25.09M
160.97%212.71M
17.94%104.89M
22.65%57.45M
Total composite income of parent company owners
-30.45%61M
-34.51%30.34M
-37.94%15.57M
-93.27%14.32M
-16.38%87.71M
-19.36%46.33M
-18.74%25.09M
160.97%212.71M
17.94%104.89M
22.65%57.45M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Beijing Dahua International Accounting Firm (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -14.80%660.85M-16.01%441.7M-15.06%177.32M-12.29%953.98M-10.76%775.67M0.26%525.91M-16.24%208.76M12.15%1.09B16.63%869.23M15.53%524.54M
Operating revenue -14.80%660.85M-16.01%441.7M-15.06%177.32M-12.29%953.98M-10.76%775.67M0.26%525.91M-16.24%208.76M12.15%1.09B16.63%869.23M15.53%524.54M
Other operating revenue -----11.64%302.94K-----17.94%726.17K-----21.27%342.83K------884.89K-----3.67%435.46K
Total operating cost -9.51%609.5M-14.47%403.64M-13.40%158.94M-9.95%870.96M-10.17%673.53M3.63%471.9M-14.64%183.52M12.64%967.23M16.29%749.81M14.63%455.36M
Operating cost -2.76%172.47M-7.10%111.79M-14.15%39.31M-11.54%218.76M-8.39%177.36M6.46%120.33M-10.96%45.79M22.93%247.29M25.99%193.6M21.01%113.03M
Operating tax surcharges 10.36%12.62M11.44%7.65M-0.46%3.44M-1.20%13.04M-2.07%11.44M10.11%6.86M-20.47%3.46M-4.87%13.2M2.87%11.68M-2.77%6.23M
Operating expense -19.93%271.3M-28.62%180.03M-22.78%77.38M-17.79%437.54M-20.87%338.81M-3.36%252.22M-17.81%100.21M12.74%532.2M16.67%428.14M17.63%260.98M
Administration expense -7.18%103.9M-3.22%70.36M12.69%29.9M6.83%151.48M12.98%111.94M11.23%72.7M-13.65%26.54M5.53%141.79M10.71%99.08M10.34%65.36M
Financial expense 74.40%19.3M78.32%12.41M3.67%3.67M7.50%12.01M133.64%11.07M296.71%6.96M18.76%3.54M-33.90%11.17M-59.10%4.74M-78.63%1.75M
-Interest expense (Financial expense) 69.78%19.61M77.37%12.77M3.66%3.85M10.58%11.8M121.37%11.55M258.28%7.2M18.49%3.71M-35.71%10.67M-58.65%5.22M-77.79%2.01M
-Interest Income (Financial expense) -51.64%-532.66K-24.99%-405.93K0.42%-199.21K-26.54%-924.33K34.88%-351.27K0.79%-324.78K-31.95%-200.05K46.79%-730.48K53.69%-539.45K66.50%-327.35K
Research and development 30.54%29.91M66.84%21.4M31.17%5.23M76.67%38.13M82.29%22.92M60.22%12.83M11.16%3.99M5.93%21.58M7.31%12.57M-1.34%8.01M
Credit Impairment Loss -34.76%-4.07M-1.95%-2.73M-1,536.08%-1.09M170.30%3.31M53.02%-3.02M30.47%-2.68M91.35%-66.53K-61.45%-4.71M-76.66%-6.42M-84.31%-3.85M
Asset Impairment Loss 97.78%-10.03K103.49%14.8K-----71.22%-630.02K-27.87%-451.3K-83.03%-423.96K-116.47%-383.35K-340.75%-367.97K-412.13%-352.93K-142.28%-231.63K
Other net revenue 898.95%18.67M-126.84%-382.81K-75.81%159.86K625.12%10.72M170.62%1.87M183.44%1.43M57.76%660.86K-74.17%1.48M-372.14%-2.65M-209.92%-1.71M
Fair value change income 158.82%10.14K138.10%4.06K358.33%15.72K-3,500.00%-17.24K---17.24K---10.65K---6.09K--507.18--------
Invest income -------------78.54%-707.21K--0.16-----------396.11K--------
Asset deal income --18.9M--32.47K--32.47K--0------------82.02%-17.1K82.02%-17.1K82.02%-17.1K
Other revenue -28.42%3.83M-49.43%2.3M7.46%1.2M25.77%8.76M29.15%5.35M89.91%4.54M-18.17%1.12M-20.99%6.97M-13.11%4.15M38.27%2.39M
Operating profit -32.68%70.01M-32.03%37.68M-28.39%18.55M-23.11%93.74M-10.94%104.01M-17.84%55.43M-25.24%25.9M4.34%121.92M15.10%116.78M19.96%67.47M
Add:Non operating Income -60.93%108.55K-51.92%103.56K-70.75%84.04K45.89%371.33K154.82%277.86K168.89%215.39K355.55%287.28K-32.08%254.53K-39.38%109.04K-7.79%80.1K
Less:Non operating expense 39.66%1.86M2,152.41%1.71M777.16%312.93K105.25%1.7M316.97%1.33M-31.79%76.11K-48.51%35.68K-1.57%826.93K-78.89%318.57K-90.97%111.58K
Total profit -33.69%68.27M-35.10%36.07M-29.95%18.32M-23.84%92.42M-11.68%102.96M-17.60%55.57M-24.50%26.15M4.27%121.34M16.41%116.57M22.41%67.44M
Less:Income tax cost -52.33%7.27M-38.04%5.73M159.79%2.74M17.50%11.55M30.48%15.24M-7.49%9.24M-71.86%1.06M-41.86%9.83M4.31%11.68M21.01%9.99M
Net profit -30.45%61M-34.51%30.34M-37.94%15.57M-27.48%80.87M-16.38%87.71M-19.36%46.33M-18.74%25.09M12.11%111.52M17.94%104.89M22.65%57.45M
Net profit from continuing operation -30.45%61M-34.51%30.34M-37.94%15.57M-27.48%80.87M-16.38%87.71M-19.36%46.33M-18.74%25.09M12.64%111.52M17.94%104.89M22.65%57.45M
Net profit of parent company owners -30.45%61M-34.51%30.34M-37.94%15.57M-27.48%80.87M-16.38%87.71M-19.36%46.33M-18.74%25.09M12.11%111.52M17.94%104.89M22.65%57.45M
Earning per share
Basic earning per share -30.06%0.2645-34.30%0.1312-37.80%0.0673-27.45%0.3489-16.38%0.3782-19.41%0.1997-18.89%0.10829.87%0.4809-18.05%0.4523-15.37%0.2478
Diluted earning per share -25.68%0.2645-30.47%0.1312-39.08%0.0622-27.78%0.3307-15.94%0.3559-18.91%0.1887-18.45%0.102112.56%0.4579-19.23%0.4234-15.90%0.2327
Other composite income -165.77%-66.55M663.07%101.19M
Other composite income of parent company owners -------------165.77%-66.55M------------663.07%101.19M--------
Total composite income -30.45%61M-34.51%30.34M-37.94%15.57M-93.27%14.32M-16.38%87.71M-19.36%46.33M-18.74%25.09M160.97%212.71M17.94%104.89M22.65%57.45M
Total composite income of parent company owners -30.45%61M-34.51%30.34M-37.94%15.57M-93.27%14.32M-16.38%87.71M-19.36%46.33M-18.74%25.09M160.97%212.71M17.94%104.89M22.65%57.45M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Beijing Dahua International Accounting Firm (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%